Targeting GRK5 for Treating Chronic Degenerative Diseases

• Published in: International journal of molecular sciences 2021-02, Vol.22 (4), p.1920
• Main Authors: Marzano, Federica, Rapacciuolo, Antonio, Ferrara, Nicola, Rengo, Giuseppe, Koch, Walter J, Cannavo, Alessandro
• Format: Article
• Language: English
• Subjects: Animals; cancer; cardiovascular; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - metabolism; G-Protein-Coupled Receptor Kinase 5 - antagonists & inhibitors; G-Protein-Coupled Receptor Kinase 5 - chemistry; G-Protein-Coupled Receptor Kinase 5 - metabolism; GPCR; GRK5; Humans; Molecular Targeted Therapy - methods; Neoplasms - drug therapy; Neoplasms - metabolism; neurodegeneration; Neurodegenerative Diseases - drug therapy; Neurodegenerative Diseases - metabolism; Receptors, G-Protein-Coupled - metabolism; Review; Signal Transduction
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22041920

G protein-coupled receptors (GPCRs) are the largest family of cell-surface receptors and they are responsible for the transduction of extracellular signals, regulating almost all aspects of mammalian physiology. These receptors are specifically regulated by a family of serine/threonine kinases, called GPCR kinases (GRKs). Given the biological role of GPCRs, it is not surprising that GRKs are also involved in several pathophysiological processes. Particular importance is emerging for GRK5, which is a multifunctional protein, expressed in different cell types, and it has been found located in single or multiple subcellular compartments. For instance, when anchored to the plasma membrane, GRK5 exerts its canonical function, regulating GPCRs. However, under certain conditions (e.g., pro-hypertrophic stimuli), GRK5 translocates to the nucleus of cells where it can interact with non-GPCR-related proteins as well as DNA itself to promote "non-canonical" signaling, including gene transcription. Importantly, due to these actions, several studies have demonstrated that GRK5 has a pivotal role in the pathogenesis of chronic-degenerative disorders. This is true in the cardiac cells, tumor cells, and neurons. For this reason, in this review article, we will inform the readers of the most recent evidence that supports the importance of targeting GRK5 to prevent the development or progression of cancer, cardiovascular, and neurological diseases.